Lifelines Neuro, Inc. Proudly Announces the Acquisition of Incereb Ltd

For Immediate Release 

Troy, IL – Oct. 8, 2018 - Lifelines Neurodiagnostic Systems, Inc., provider of neurodiagnostic equipment and services, announces the acquisition of Incereb Ltd, Dublin, Ireland, through its sister company Lifelines Neuro, Inc.  Incereb is the manufacturer of the neon neonatal EEG electrode array.

Simon Griffin, CEO of Lifelines, says of the acquisition, “We have been working with Incereb for several years in the US market, and their neon product is a perfect fit with our technology and growth plans. We are very excited not only to work with Jim Roche and Incereb on new product development, but also with the INFANT Centre at University College Cork and the fantastic research being performed there under the stewardship of Professor Geraldine Boylan.”

Incereb was acquired through a share sale for an undisclosed fee. The company will remain operating in Dublin, Ireland as a subsidiary of the Lifelines group of companies. Plans are to increase R&D spending on a new product pipeline, and grow the business by developing new markets and product lines.

“This is a perfect fit for Incereb in terms of our product offering and Lifelines’ sales and distribution network,” says Incereb CEO, Jim Roche, of the acquisition. Incereb has been working with Lifelines since 2015 to distribute Incereb in the US, and more recently worldwide.

“Declan O’Mahoney, Incereb director, has worked tirelessly with the management team consisting of Simon Forsyth, Paul Phillips, and me to get Incereb to this next stage of its evolution,” says Roche. “We are delighted with this acquisition and look forward to growing our business and product range together to bring neonatal and intensive care neuroprotective monitoring to the next level.”


About Lifelines

The Lifelines group of companies brings together products and services from around the globe, to advance its mission of changing lives through neurodiagnostic innovation.

Lifelines has design and manufacturing facilities in the United Kingdom and Ireland, and distributes products and services around the globe. Its headquarters, in Troy, IL also serves as the US distribution site.  The company provides electroencephalography (EEG) solutions for a number of market niches, specializing in underserved segments where EEG is traditionally difficult to record.

Lifelines’ exceptional hardware and cloud software break down barriers to performing EEG in the NICU, ED, ICU, veterinary practices, and in patients’ homes.

Lifelines’ solutions empower physicians, EEG service providers, research leaders, EEG technologists, and veterinarians with the highest-quality neurodiagnostic and research tools on the market. Our years of dedication to the understanding of neurodiagnostics serve our clients as their foundation for growth. Our unmatched customer support helps improve patient care and safety, processes, research, operational efficiency, and financial performance.

About Incereb

Increb Limited, an ISO 13485 certified company, has developed a range of sensors for use in the neonatal intensive care unit (NICU) for the purpose of EEG brain monitoring and physiological measurement signal applications.  The first product on the market is the neon EEG product range (CE marking and FDA 510(k) cleared.)

Jim Roche founded the company in 2012 with investment from Enterprise Ireland, ACT Venture Capital, Delta Partners VC, HBAN, and private investors.  Incereb is an industry partner in the Science Foundation Ireland-funded INFANT Centre based at University College Cork under the directorship of Professor Geraldine Boylan.

These are the first EEG electrode devices designed and manufactured specifically for the neonatal market, and can significantly reduce application time from one hour to several minutes without the need for trained specialists. This enables clinicians to monitor brain activity quickly and efficiently for seizures in the first 24/36 hours of life.

We use cookies, just to track visits to our website, we store no personal details. Our Privacy and Cookies Policy